1. 2859 A multicenter phase II of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullar thyroid carcinoma: Mature data of THYSU study. (September 2015) Authors: De La Fouchardiere, C.; Delord, J.P.; Bazignan, A. Doussau De; Catargi, B.; Docao, C.; Asselineau, J.; Picat, M.Q.; Rodien, P.; Pouessel, D.; Nicolli-Sire, P.; Klein, M.; Bournaud-Salinas, C.; Caron, P.; Wemeau, J.L.; Gimbert, A.; Sitta, R.; Digue, L.; Ravaud, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 308 Phase I of axitinib and everolimus in metastatic solid tumors and extension to metastatic renal cell carcinoma (mrcc): Results of EVAX study. (September 2015) Authors: Ravaud, A.; Gomez-roca, C.; Picat, M.Q.; Digue, L.; Chevreau, C.; Gimbert, A.; Chauzit, E.; Asselineau, J.; Cornelis, F.; Sitta, R.; Aziza, R.; Daste, A.; Bikfalvi, A.; Pedenon-perichout, D.; Doussau, A.; Molimard, M.; Delord, J.P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase Ib trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors. (December 2016) Authors: Massard, C.; Soria, J.C.; Stathis, A.; Delord, J.P.; Awada, A.; Peters, S.; Lewin, J.; Bekradda, M.; Rezai, K.; Zeng, Z.; Azher, H.; Perez, S.; Siu, L. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors. (19th April 2015) Authors: Vigarios, E.; Lamant, L.; Delord, J.P.; Fricain, J.C.; Chevreau, C.; Barrés, B.; Gomez‐Roca, C.; Boulanger, M.; Sibaud, V. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1680 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors. (19th April 2015) Authors: Vigarios, E.; Lamant, L.; Delord, J.P.; Fricain, J.C.; Chevreau, C.; Barrés, B.; Gomez‐Roca, C.; Boulanger, M.; Sibaud, V. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1680 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors. (1st June 2015) Authors: Vigarios, E.; Lamant, L.; Delord, J.P.; Fricain, J.C.; Chevreau, C.; Barrés, B.; Gomez‐Roca, C.; Boulanger, M.; Sibaud, V. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1680 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SP-0598: Cilengitide in continuous infusion with radio-chemotherapy in stage III NSCLC: A phase I clinical trial. (April 2015) Authors: Cohen-Jonathan Moyal, E.; Massabeau, C.; Filleron, T.; Modesto, A.; Bachaud, J.M.; Rouquette, I.; Dierickx, L.; Aziza, R.; Bigay-Game, L.; Plat, G.; Mounier, M.; Gomez-Roca, C.; Delord, J.P.; Mazieres, J. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. T‐DM1 extravasation: first description. (16th April 2015) Authors: Sibaud, V.; Nougarolis, S.; Borjesson, C.; Gangloff, D.; Delord, J.P.; Pompa, V.; Saintenac, D.; Roche, H. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 7(2016:Jul.) Page Start: 1235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗